Knapton (pictured) has held the position since 2011 and will remain on the board of directors following the identification of, and transition to, his successor. He has chosen to resign following his father’s diagnosis with Amyotrophic Lateral Sclerosis (ALS).

“The board of directors of Research Now is supportive of the personal decision Kurt is making at this time,” said John Civantos, board member and managing partner at Court Square Capital Partners, the majority owner of Research Now.

“We want to thank Kurt for his visionary leadership and are tremendously appreciative of the industry-leading company Kurt helped launch and grow during his twelve years of total service at the company. We will continue to benefit from Kurt’s ongoing involvement as a board member and significant investor in Research Now, and we will quickly move to identify his successor and ensure a smooth transition.”